Net Underwriting Profit -- $13 million reported, yielding a combined ratio of 92.1% for the quarter. Net Income (Q4) -- $49.3 million, translating to $1.44 per diluted share. Innovations Segment -- ...

Researchers create the first sex-specific GLP-1 brain atlas, revealing why weight-loss drugs work differently in men and women.

Korn Ferry (NYSE:KFY) Q3 2026 Earnings Call Transcript March 9, 2026 Korn Ferry beats earnings expectations. Reported EPS is $1.24, expectations were $1.22. Operator: Ladies and gentlemen, thank you ...

Airtime depreciation expense -- Non-cash expense equal to 89% of service revenue in both fiscal Q4 and Q3 2025. Legacy network cost reduction -- Minimum bandwidth commitment to decrease by $7 million ...

Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...

FuelCell Energy, Inc. (NASDAQ:FCEL) Q1 2026 Earnings Call Transcript March 9, 2026 FuelCell Energy, Inc. beats earnings expectations. Reported EPS is $-0.49081, expectations were $-0.68. Operator: ...

Barclays 28th Annual Global Healthcare Conference March 10, 2026 8:00 AM EDTCompany ParticipantsMark Kaye - Executive VP ...

Revenue -- $42.4 million for the quarter, representing a 14.3% decrease year over year, mainly attributed to fewer orders ...

Creative Media (NASDAQ: CMCT) released fourth-quarter financial results and hosted an earnings call on Monday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs.

CLEVELAND, Ohio — The calendar says spring training. The scoreboard says something else entirely. Starting pitchers are ...

The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the ...

Tuesday, March 10, 2026 at 9 a.m. ET Chairman of the Board and Chief Executive Officer — John L. Erb Chief Financial Officer — Carissa Schultz Vice President, Investor Relations — Leah McMullen ...